Table 3.

Anthropometric indices and blood pressure before and after the trial (mean ± SD).

Variables		Mean ± SD		p value2	p value3
		Synbiotics (n = 52	Placebo (n = 56)
Weight (kg)	Baseline	84.28 ± 14.92	82.04 ± 14.24	0.503
	At 12 wk	82.12 ± 14.29	79.43 ± 13.55	0.325
	p value1	<0.001	<0.001		0.420
BMI	Baseline	31.03 ± 4.91	31.14 ± 5.33	0.91
	At 12 wk	30.67 ± 4.73	30.62 ± 5.29	0.84
	p value1	<0.001	<0.001		0.31
WC (cm)	Baseline	104.84 ± 9.74	104.60 ± 9.99	0.900
	At 12 wk	99.49 ± 8.98	99.53 ± 10.38	0.981
	p value1	<0.001	<0.001		0.640
HC (cm)	Baseline	108.86 ± 9.90	109.28 ± 10.22	0.82
	At 12 wk	104.50 ± 9.07	104.38 ± 9.06	0.94
	p value1	<0.001	<0.001		0.56
WHR	Baseline	0.93 ± 0.06	0.94 ± 0.06	0.78
	At 12 wk	0.90 ± 0.06	0.91 ± 0.05	0.52
	p value1	<0.001	<0.001		0.58
SBP (mmHg)	Baseline	118.98 ± 12.94	120.85 ± 14.23	0.486
	At 12 wk	114.19 ± 11.31	113.76 ± 10.30	0.841
	P value1	0.039	<0.001		0.272
DBP (mmHg)	Baseline	81.22 ± 8.7	81.94 ± 9.45	0.686
	At 12 wk	79.30 ± 8.85	78.29 ± 7.14	0.530
	p value1	0.147	0.014		0.480
LBM (kg)	Baseline	54.72 ± 11.30	52.82 ± 9.55	0.34
	At 12 wk	55.10 ± 11.31	52.69 ± 9.16	0.23
	p value1	0.55	0.78		0.75
Body proteins (kg)	Baseline	10.52 ± 2.38	10.11 ± 2.00	0.33
	At 12 wk	10.57 ± 2.34	10.16 ± 2.05	0.34
	p value1	0.04	0.03		0.98
Body fat (%)	Baseline	35.53 ± 5.76	35.94 ± 6.37	0.72
	At 12 wk	33.81 ± 6.40	33.74 ± 7.26	0.95
	p value1	<0.001	<0.001	0.39

p value¹: significance of within-group alterations (paired t-test); p value²: significance of between-group alterations (independent t-test); p value³: treatment by analysis of covariance (adjusted baseline variable). WC: waist circumference; BMI: body mass index; HC: hip circumference; WHR: waist–hip ratio; LBM: loan body mass SBP: systolic blood pressure; DBP: diastolic blood pressure.